Fertility-female
Conditions
Interventions
Group A. 50mg oral diclofenac potassium and and 20mg intramuscular hyoscine
Group B. 50mg oral diclofenac potassium and sterile water for injection water
Sponsors
Ojie Chukwunekwu Victory
Eligibility
Sex/Gender
Female
Inclusion criteria
Inclusion criteria: These were women requiring HSG for evaluation of infertility, and who consented to participate in the study. Infertile women undergoing HSG investigations for the first time (i.e. had no prior experience of the pains associated with the procedure). those with no cognitive or visual impairment (and hence will not have difficulty understanding or completing the assessment tools). Patients who are at least 18 years of age.
Exclusion criteria
Exclusion criteria: Women who have documented allergy or known hypersensitivity to diclofenac potassium, hyoscine or urografin dye, known gastroesophageal disease, known cervical stenosis, presence of acute pelvic inflammatory disease, Active cervical lesion or endometrial infection, vaginal bleeding, or known reproductive tract malignancy.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The primary outcome measure was the severity of pain in both study arms determined using the visual analogue score | — |
Secondary
| Measure | Time frame |
|---|---|
| The secondary outcome measures were an impression of cornnual spasm on radiological image assessment, patient satisfaction assessed at 30 minutes post-procedure, measured with a validated satisfaction survey, and the adverse effects of the medications experienced by women (nausea, vomiting, fainting, headache, hypotension). | — |
Countries
Nigeria
Contacts
Public ContactChukwunekwu Ojie
Consultant Obstetrician and Gynaecologist Central Hospital Warri Delta State Nigeria
Outcome results
None listed